Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

VIVS vs AMD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AMD Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 10–0 Matrix Metrics)

AMD Overall Winner 6-Pillar Tally: VIVS 0 – 6 AMD Matrix Metrics: VIVS 0 – 10 AMD

As of Nov 19, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over VivoSim Labs, Inc. (VIVS) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). VIVS carries a Unified Composite Score of 36.8/100 (SELL) at $0.29 (N/M Forward P/E, -10117.0% operating margin), whereas AMD carries 46.7/100 (HOLD) at $489.19 (27.3x Forward P/E, 17.8% operating margin).

  • Technical & Structure Timing Caution: VIVS is currently in a Breakdown options structure phase (RSI 75.1); meanwhile AMD trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 45.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VIVS vs AMD
VIVS NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap $2.4M
TTM Revenue $112,000
Forward P/E N/M
Beta / 30D Vol 0.83β · 480% Vol
Unified Composite Score
36.8 / 100 SELL
Tech 5.0 Fund 38.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 75
RSI-14: 75.1 · SMA20: $0.15 · SMA50: $0.18
AMD NASDAQ Head-to-Head Winner
Advanced Micro Devices
Semiconductors & Related Devices
$489.19
-7.72% 1D
Market Cap $877.4B
TTM Revenue $45.4B
Forward P/E 27.3x
Beta / 30D Vol 3.61β · 120% Vol
Unified Composite Score
46.7 / 100 HOLD
Tech 18.0 Fund 38.0 Flow 58.0 Mom 44.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.2 · SMA20: $513.70 · SMA50: $554.93

6-Pillar Scorecard Institutional Category Breakdown (VIVS 0 – 6 AMD)

Columns: Metric · VIVS · AMD
1. Valuation Multiples AMD
Forward P/E N/M 27.3x
Trailing P/E N/M 113.3x
PEG Ratio N/M 0.45x
EV / Revenue 9.6x 19.3x
2. Growth & Scale AMD
Revenue Growth (YoY) -51.4% +44.7%
Earnings Growth (YoY) +0.0% +93.8%
TTM Revenue (USD) $112,000 $45.4B
Market Cap $2.4M $877.4B
3. Profitability & Quality AMD
Gross Margin N/A 56.0%
Operating Margin -10117.0% 17.8%
Net Profit Margin 0.0% 16.8%
Return on Equity (ROE) -343.1% 12.0%
4. Balance Sheet & Cash Flow AMD
Cash Generation (TTM) -$11M EBITDA $7.06B
Cash Flow Margin N/A 15.5%
Net Cash / Leverage $1.4M Net Cash $1.51B Net Debt (0.13x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning AMD
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile N/A (N/A) 128.2% (17th %ile)
Put/Call OI Skew N/A 1.08x (Balanced)
OBV Trend / Tech Phase ACCUMULATION · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat AMD
OpEx & R&D Intensity N/A 38.2% of Rev ($17.4B)
90D R&D Disclosures 0 papers 7 papers
Competitive Moat Cyclical / Execution-Driven Positioning Concentrated Oligopoly Moat
Supply-Chain Role Biotechnology Operator AI Accelerator & Server Chiplet Designer

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VIVS (0) vs AMD (10)
Institutional Metric VIVS AMD Criterion Row Edge
Market Capitalization
Scale
$2.4M $877.4B Larger Scale AMD
Trailing P/E Ratio
Valuation
N/M 113.3x Lower Multiple AMD
Forward P/E Ratio
Valuation
N/M 27.3x Lower Multiple AMD
Revenue Growth (YoY)
Growth
-51.4% +44.7% Higher Growth AMD
Operating Margin (TTM)
Profitability
-10117.0% 17.8% Higher Margin AMD
Net Profit Margin
Profitability
0.0% 16.8% Higher Margin AMD
Return on Equity (ROE)
Capital Efficiency
-343.1% 12.0% Higher ROE AMD
52-Week Range Position
Momentum
5% ($0–$3) 64% ($188–$659) Stronger Trend AMD
Beta / 30D Volatility
Risk Regime
0.83β · 480% Vol 3.61β · 120% Vol Lower Realized Risk AMD
Unified Institutional Score
Composite Signal
36.8 / 100 (SELL) 46.7 / 100 (HOLD) Higher Composite AMD
Trailing 12M Revenue (USD)
Operating Scale
$112,000 $45.4B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 56.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 9.6x EV/Rev 0.45x PEG · 19.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$11M EBITDA ($1.4M Net Cash) $7.06B ($1.51B Net Debt (0.13x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VIVS +76.18 pp
VIVS: +64.69% · AMD: -11.49%
3M Horizon AMD +1.45 pp
VIVS: +1.92% · AMD: +3.37%
6M Horizon AMD +87.06 pp
VIVS: -78.25% · AMD: +8.81%
1Y Horizon AMD +199.41 pp
VIVS: -86.99% · AMD: +112.42%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period VIVS Revenue AMD Revenue VIVS Op. Margin AMD Op. Margin Margin Leader
FY2019 $0M $6.73B -882.4% 9.4% AMD
FY2020 $0M $9.76B -977.9% 14.0% AMD
FY2021 N/A $16.4B N/A 22.2% AMD
FY2022 $0M $23.6B -765.3% 5.4% AMD
FY2023 $0M $22.7B -4792.2% 1.8% AMD
FY2024 $0M $25.8B -13840.4% 7.4% AMD
FY2025 $0M $34.6B -8761.1% 10.7% AMD
FY2026 $0M N/A -8768.7% N/A VIVS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VIVS BREAKDOWN
73d in phase · OBV ACCUMULATION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact VIVS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AMD CONSOLIDATION
106d in phase · OBV NEUTRAL
Current IV 128.2%
IV Percentile 17th %ile
Put/Call OI Skew 1.08x (Balanced)
IV Regime Compressed (<25th %ile)
Put Wall Floor $450.00
Call Wall Magnet $500.00
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Put Floor: $450.00 (-8.0%) Spot: $489.19 Call Magnet: $500.00 (+2.2%)
  • Extended consolidation (106 days)
  • IV expanding (+13.5%) but put wall rising - pre-earnings positioning (neutral)
  • Put wall rising (+$50) - support strengthening
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $504.28 · IV 73.5%

AMD Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($50,428)

Compare $50,428 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 73.5% ATM IV.

5-DAY BULLISH SWING Liq A

Dec 18 $510 / $580 Bull Call Spread

Buy 1x $510C · Sell 1x $580C · 31d

Net Entry $2,436 Debit
T+5d @ +5% Move +$583 (+24%)
Max Risk / Buffer $2,436 Capped
5d Edge & Liquidity 0.7x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $440 / $410 Bull Put Spread

Sell 1x $440P · Buy 1x $410P · 31d

Net Entry $731 Credit
Max Credit / Yield +$731 (+32.2% RoM)
Max Risk / Buffer -14.2% Cushion ($2,269 Mgn)
5d Edge & Liquidity 76% PoP · Liq A
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq A

Dec 18 $450P / $520-$590C Seagull

Sell 1x $450P · Buy 1x $520/$590C · 31d

Net Entry $52 Debit
T+5d @ +5% Move +$1,463 (+21.3% RoM)
Max Risk / Buffer -10.8% Put Cushion ($6,861 Mgn)
5d Edge & Liquidity 1.0x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VIVS Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $2.4M market capitalization and -10117.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
AMD Moat Profile Concentrated Oligopoly Moat
AI Accelerator & Server Chiplet Designer
Data center GPU accelerators and server CPU chiplets scale directly with upstream leading-edge foundry utilization and cloud server integration.
OpEx & R&D Reinvestment 38.2% of Rev ($17.4B)
90D Engineering Disclosures 7 Published · LLM Efficiency / Architecture
Mapped Supply-Chain Ecosystem (18 partners):
Taiwan Semiconductor Manufacturing Company GlobalFoundries Samsung Electronics ASE Technology Holding
Active 90D Technical Topics:
Edge AI / Inference Chips Hardware-Agnostic ML Compilers Inference Serving / Speculative Decoding KV-Cache / Attention Memory Compression Mixture-of-Experts / Sparse Models

Investor FAQ VIVS vs AMD Key Questions & Quantitative Answers

As of Nov 19, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over VivoSim Labs, Inc. (VIVS) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). VIVS carries a Unified Composite Score of 36.8/100 (SELL) at $0.29 (N/M Forward P/E, -10117.0% operating margin), whereas AMD carries 46.7/100 (HOLD) at $489.19 (27.3x Forward P/E, 17.8% operating margin). Technical & Structure Timing Caution: VIVS is currently in a Breakdown options structure phase (RSI 75.1); meanwhile AMD trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 45.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AMD leads the Growth & Scale pillar: VIVS posts -51.4% YoY revenue growth and +0.0% YoY earnings growth on $112,000 TTM revenue (N/A gross margin, -10117.0% operating margin), compared with AMD at +44.7% YoY revenue growth and +93.8% YoY earnings growth on $45.4B TTM revenue (56.0% gross margin, 17.8% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), VIVS cumulative revenue shifted N/A while AMD shifted +414.7%. In operating R&D and SG&A reinvestment, VIVS deploys N/A (0 90-day corporate R&D disclosures) versus 38.2% of Rev ($17.4B) (7 disclosures) for AMD.

AMD screens cheaper on headline valuation multiples. VIVS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 9.6x EV/Revenue (unreported EBITDA margin), whereas AMD trades at 27.3x Forward P/E, 113.3x Trailing P/E, 0.45x PEG, and 19.3x EV/Revenue (15.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VIVS (-343.1% ROE) versus AMD (12.0% ROE) capital efficiency.

In options market volatility and institutional positioning, VIVS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (0.83β · 480% Vol realized risk). By comparison, AMD carries 128.2% implied volatility (17th %ile, Compressed (<25th %ile)), a 1.08x (Balanced) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (3.61β · 120% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.